Nevertheless, the absence of insulin-antagonizing GH action led to undisturbed glucose tolerance, similar to findings in the Ecuadorian cohort of human Laron syndrome patients, who display an increased insulin sensitivity despite obesity. This evidence concerns the gene INS and Laron syndrome.